Science News Roundup: J&J's Stelara succeeds in chronic bowel disease study
Following is a summary of current science news briefs.
J&J's Stelara succeeds in chronic bowel disease study
Johnson & Johnson said on Tuesday its blockbuster drug Stelara was found to be effective in treating a chronic bowel disease in a late-stage trial. Two doses of Stelara, already approved for psoriasis, psoriatic arthritis and Crohn's disease, was tested in 961 patients with moderate-to-severe ulcerative colitis (UC) who had failed prior therapy.
(With inputs from agencies.)
Advertisement
ALSO READ
BJP manifestoes have always brought destruction for J-K: Omar Abdullah
UNESCO discusses reshaping Sudan's education landscape amid current emergency
More research needed to address impact of harmful masculinities on sexual and reproductive health
Rogue waves in the ocean are much more common than anyone suspected, says new study
Excise scam case: CBI produces BRS leader K Kavitha before Delhi court.